CAYLA DARNELL: Open Payments
NPI 1093370983 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,954 in 140 payments from 14 companies in 2025. Trend: 2023 $100 · 2024 $1,997 · 2025 $1,954
Food & beverage: $1,954
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $404 |
| PFIZER INC. | 32 | $290 |
| Eisai Inc. | 9 | $287 |
| Lundbeck LLC | 20 | $262 |
| Axsome Therapeutics, Inc. | 5 | $185 |
| Neurocrine BioSciences, Inc. | 9 | $154 |
| Teva Pharmaceuticals USA, Inc. | 7 | $134 |
| Lilly USA, LLC | 4 | $74 |
| Dexcom, Inc. | 1 | $39 |
| Neurelis, Inc. | 2 | $36 |
Products named: NURTEC ODT, Leqembi, QULIPTA, VYEPTI, Symbravo, INGREZZA, AUSTEDO XR, UBRELVY.
Industry payments across IN — which companies pay providers there.
